Larson Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6K Hold
500
﹤0.01% 2154
2026
Q1
$67.7K Buy
+500
New +$507K ﹤0.01% 1183

Other funds holding LLY

Larson Financial Group's LLY Position: Q2 2026 in Review

Larson Financial Group increased its Eli Lilly (LLY) stake by 28% in Q2 2026, buying an estimated $4.92M and bringing the position to 21,831 shares worth $26.2M. The position accounts for 0.69% of the portfolio, ranked #33.

Larson Financial Group first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Larson Financial Group held 21,831 shares of Eli Lilly worth $26.2M as of Q2 2026.
  • Larson Financial Group bought 4,817 Eli Lilly shares in Q2 2026, an estimated $4.92M.
  • Eli Lilly made up 0.69% of Larson Financial Group's portfolio in Q2 2026, its #33 holding.
  • Larson Financial Group first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.